Workshop

Drug Delivery Day: Designing and developing a successful formulation

December 5, 2024​​ | San Diego, California, USA


Overview

Evonik Health Care is excited to present our first ever full-day Drug Delivery workshop! Focusing on both oral and parenteral technologies, Evonik’s team has created an agenda full of everything you need to know when designing your formulation.

In this one-day workshop, Evonik’s Drug Delivery experts will share their experiences and insights on the discovery and development of oral formulations, long-acting injectables and RNA-based therapies and mRNA vaccines. As a CDMO partner offering end-to-end solutions, Evonik has decades of experience and expertise in every step of the manufacturing process, including route scouting, process development and optimization, purification, isolation, characterization, scale-up, and commercialization.

This workshop will feature presentations on:

  • the use and application of EUDRAGIT® polymers and EUDRATEC® technologies in delayed release, sustained release, controlled release, taste masking, and moisture protection,
  • current advances in leveraging novel lipids, such as randomized PEGs (rPEGs) in LNP-based delivery systems,
  • and GMP manufacturing considerations for both parenteral excipients and drug products, focusing on product-by-process manufacturing, ocular implants, microparticles and nanoparticles.


Key learnings for participants

  • Introduction to capabilities necessary to support oral and parenteral development and manufacturing
  • Understanding how to best use the EUDRAGIT® and EUDRATEC®
  • Technologies for your oral formaultions
  • Brief history of long-acting polymeric injectable drug products on the market, including microparticles and implants
  • Custom polymer and lipid synthesis, parenteral drug services for formulations
  • And more!

Note: Please fill in your details and click 'Submit' to register for the workshop. Once we have received your registration, we will send you a status notification as soon as possible. Due to the high demand for our workshops, we sometimes need to reject registrations or put you on a waiting list. Workshop materials will be available for download at the end of the workshop. Any photographs taken during the event are the property of Evonik and may be used for promotional purposes.

Details
Participation fee: $50
Workshop language: English



Agenda
The workshop will start at 08:30 a.m. on Thursday, December 5, 2024, and finish at 7:00 p.m. on the same day. To see the detailed workshop program please click here.



Venue
The workshop will take place at:
San Diego Marriott La Jolla Hotel,
4240 La Jolla Village Drive,
La Jolla, CA 92037

Fill out the form to register for the workshop:

Agenda

08:30 | Registration and Breakfast​

09:00 | Welcome and Introduction

09:30 | Overview of EUDRAGIT® ​

10:00 | Solubility Enhancement of Poorly Soluble Drugs Using EUDRAGIT® Polymeric Excipient & EUDRATEC® SoluFlow – A Free-Flowing Amorphous Solid Dispersion Technology
Dr. Irfan Syed
Associate Director, FAS
Evonik Health Care

10:30 | Coffee Break & Networking

11:00 |Customized Release With  EUDRATEC® Technologies
Dr. Manish Rane
Associate Director, Technical Sales
Evonik Health Care

11:30 | EUDRACAP®  ready-to-fill Capsules Enhance Functional Performance
Dr. Kamlesh Oza
Head of Technical Sales NA, Formulation & Application Services
Evonik Health Care

12:00 | Oral Formulations Q&A

12:15 | Lunch and Networking 

1:15 | Long-acting Formulations – Polymeric Microparticles and Implants
Dr. Tom Tice
Senior Director, Technical Marketing
Evonik Health Care

2:00 | Choosing the Right Bioresorbable Polymer for your Formulation
Dr. Manish Rane
Associate Director, Technical Sales
Evonik Health Care

2:15 | Custom Formulation Development and Production
Dr. Tom Tice
Senior Director, Technical Marketing
Evonik Health Care

2:45 | Coffee Break and Networking

3:00 | Lipids, Learnings & Future Opportunities

3:30 | LNP Mixing Technologies
Dr. Michael Parr
Director Formulation and Process Development
Evonik Health Care

4:15 | Parenteral Formulations Q&A

4:30 | Wrap Up

5:00 | Happy Hour Reception



​
Disclaimer
Notice for business transactions
We assume that you are not currently or foreseeably involved in a business decision in favour of or in direct connection with the Evonik Group or, if this is the case, the decision will not be influenced by this invitation. Therefore, we do not see any concerns on our part regarding your participation. However, we would like to ask you to ensure that you are allowed to accept the invitation in accordance with the regulations that apply to you.

Note for public officials
We assume that you are not or have not been involved in any official act in favour of or in connection with the Evonik Group, either now or in the foreseeable future or in the past and therefore your participation in the event is not subject to any concerns. In addition, we ask you to ensure that your superior approves your participation or you may also accept the invitation in accordance with the rules applicable to you. By registering or participating, you confirm to us that the acceptance of this invitation is permitted according to your internal rules and that you have obtained all necessary approvals. If this is not the case, we ask you for a corresponding note.

Tax notices
Any tax liability resulting from this event will be borne by Evonik Industries AG through a flat-rate tax levy pursuant to Section 37b of the German Income Tax Act (EStG). If you are not taxable in Germany, please clarify whether you must report the invitation to your employer for taxation or whether taxation must be made via your income tax return.



QUESTIONS? 

Emily Peters
Regional Marketing Manager, North America
Phone: +1 732 668-5892

Cléa Michel

Cléa Michel is product manager for Cell Culture Ingredients at Evonik Health Care. She provides biopharma companies and media manufacturers with the finest specialty ingredients to increase cell culture performance. Cléa has a background in biochemistry and biotechnology engineering and holds a master’s degree from the National Institute of Applied Sciences in Lyon, France. She has held various positions in marketing, project management and business development and is passionate about innovative solutions that enable the successful development of life-saving biopharmaceuticals.
Dr. Stephan Brinkmann

Stephan Brinkmann works as project manager and head of Evonik's Biopharma Applications group at Evonik R&D for the Health Care business line. He is responsible for biopharma innovation projects as well as application tests of Evonik's cell culture ingredients (i.e., cQrex® peptides). Stephan studied molecular biotechnology at Bielefeld University in Germany, where he specialized in biopharma upstream and downstream process development. Before joining Evonik, Stephan worked in Switzerland on industrial mammalian cell line development for the production of therapeutic biologics. Stephan obtained his Ph.D. in a public private partnership with Sanofi and later Evotec at Fraunhofer IME in Giessen with a focus on the discovery of natural products, especially peptides.